Faron Pharmaceuticals Oy

AIM:FARN Stock Report

Market Cap: UK£149.1m

Faron Pharmaceuticals Oy Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Juho Jalkanen

Chief executive officer

€511.7k

Total compensation

CEO salary percentage77.8%
CEO tenureless than a year
CEO ownershipn/a
Management average tenureless than a year
Board average tenure3.4yrs

Recent management updates

Recent updates

Faron Pharmaceuticals Oy's (LON:FARN) Intrinsic Value Is Potentially 74% Above Its Share Price

Aug 02
Faron Pharmaceuticals Oy's (LON:FARN) Intrinsic Value Is Potentially 74% Above Its Share Price

Do Institutions Own Faron Pharmaceuticals Oy (LON:FARN) Shares?

Mar 05
Do Institutions Own Faron Pharmaceuticals Oy (LON:FARN) Shares?

What Type Of Shareholders Make Up Faron Pharmaceuticals Oy's (LON:FARN) Share Registry?

Nov 20
What Type Of Shareholders Make Up Faron Pharmaceuticals Oy's (LON:FARN) Share Registry?

CEO Compensation Analysis

How has Juho Jalkanen's remuneration changed compared to Faron Pharmaceuticals Oy's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-€32m

Mar 31 2024n/an/a

-€31m

Dec 31 2023€512k€398k

-€31m

Sep 30 2023n/an/a

-€30m

Jun 30 2023n/an/a

-€29m

Mar 31 2023n/an/a

-€29m

Dec 31 2022€635k€539k

-€29m

Sep 30 2022n/an/a

-€26m

Jun 30 2022n/an/a

-€24m

Mar 31 2022n/an/a

-€22m

Dec 31 2021€450k€381k

-€21m

Sep 30 2021n/an/a

-€21m

Jun 30 2021n/an/a

-€20m

Mar 31 2021n/an/a

-€19m

Dec 31 2020€424k€324k

-€17m

Sep 30 2020n/an/a

-€16m

Jun 30 2020n/an/a

-€14m

Mar 31 2020n/an/a

-€14m

Dec 31 2019€273k€257k

-€13m

Sep 30 2019n/an/a

-€13m

Jun 30 2019n/an/a

-€12m

Mar 31 2019n/an/a

-€16m

Dec 31 2018€361k€221k

-€20m

Sep 30 2018n/an/a

-€24m

Jun 30 2018n/an/a

-€28m

Mar 31 2018n/an/a

-€25m

Dec 31 2017€388k€235k

-€21m

Compensation vs Market: Juho's total compensation ($USD532.89K) is about average for companies of similar size in the UK market ($USD736.31K).

Compensation vs Earnings: Juho's compensation has been consistent with company performance over the past year.

CEO

Juho Jalkanen (46 yo)

less than a year

Tenure

€511,731

Compensation

Dr. Juho Markku Jalkanen, M.D., MSc & Ph D., is Founder of Faron Pharmaceuticals Oy and serves as its Chief Executive Officer and Director since May 1, 2024 and served as its Chief Operating Officer since...

Leadership Team

NamePositionTenureCompensationOwnership
Juho Jalkanen
Founderless than a year€511.73kno data
Yrjö Erik Wichmann
Interim Chief Financial Officerless than a year€455.09kno data
Maija Hollmen
Chief Scientific Officer1.9yrsno datano data
Vesa Karvonen
General Counselno datano datano data
Jennifer Smith-Parker
Head of Communicationsno datano datano data
Juhana Heinonen
Chief Commercial Officer6.8yrsno datano data
Petri Bono
Chief Medical Officerless than a yearno datano data

0.6yrs

Average Tenure

53yo

Average Age

Experienced Management: FARN's management team is not considered experienced ( 0.6 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Juho Jalkanen
Founderless than a year€511.73kno data
Markku Jalkanen
Non- Executive Director18.1yrs€511.73k3.26%
£ 4.9m
Huaizheng Peng
Board Observer6.2yrs€36.20kno data
John Poulos
Independent Non-Executive Director7.5yrs€42.00k0.0096%
£ 14.3k
Tuomo Patsi
Independent Non-Executive Chairman1.7yrs€20.97k0.011%
£ 16.8k
Marie-Louise Fjallskog
Independent Non-Executive Director1.2yrsno datano data
Christophe Massard
Member of the Scientific Advisory Board5.2yrsno datano data
Christine Roth
Independent Non-Executive Director1.2yrsno datano data

3.4yrs

Average Tenure

61yo

Average Age

Experienced Board: FARN's board of directors are considered experienced (3.4 years average tenure).